Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at DTP3 for lymphoma or myeloma

Overview

Cancer types:

Blood cancers, Cell type, High grade lymphoma, Lymphoma, Myeloma, Non-Hodgkin lymphoma (NHL)

Status:

Open

Phase:

Phase 1/2

Details

This trial is looking at a new drug called DTP3 for diffuse large B cell lymphoma or myeloma.

It is for people whose treatment has stopped working or their cancer has got worse.

Recruitment start: 1 July 2022

Recruitment end: 31 March 2027

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Aris Chaidos

Supported by

Imperial College London

Institute of Cancer Research (ICR)

Medical Research Council (MRC)

Last reviewed: 14 Mar 2025

CRUK internal database number: 18444

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.